Fluvastatin Capsule
Product Images NDC 71335-2661

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Fluvastatin (NDC 71335-2661). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula For Fluvastatin (Image 1)

Chemical structure diagram of Fluvastatin, showing molecular components including a fluorophenyl group, hydroxyl groups, and a sodium ion (Na+). This structural formula represents the active ingredient Fluvastatin from the product data.*

FDA Label Image

1 (Image 2)

A survival curve chart comparing the percentage of patients without events over 4.5 years since randomization between Fluvastatin 80 mg and Placebo groups. The y-axis represents the percentage of patients without events, and the x-axis shows years since randomization. Statistical values such as Cox P-Value, Log-Rank P-Value, and Hazard Ratio with confidence intervals are included.*

FDA Label Image

1 (Image 3)

A forest plot chart displaying the effects of Fluvastatin versus placebo on various cardiac events, showing incidence rates, risk reduction percentages, and confidence intervals. The plot includes primary and secondary endpoints such as cardiac death, myocardial infarction, and revascularization, with horizontal lines indicating risk reduction confidence intervals.*

FDA Label Image

1 (Image 4)

A bar chart showing change in minimum lumen diameter (mm) comparing Fluvastatin and placebo across three groups: Monotherapy, All Patients, and Combination Therapy with cholestyramine (CME). Each group has two bars representing Fluvastatin and placebo with respective negative change values and p-values indicating statistical significance.*

FDA Label Image

1 (Image 5)

Bar graph showing percentage change in diameter stenosis for Fluvastatin versus Placebo treatments in three groups: Monotherapy, All Patients, and Combination Therapy with cholestyramine (CME). The graph includes p-values indicating statistical comparisons between treatments for each group.*

FDA Label Image

Label (Lbl713352661)

Fluvastatin Capsules, USP 40 mg oral capsule label with NDC 71335-2661-1. The label shows 100 capsules, repackaged by Bryant Ranch Prepack, Inc. and manufactured by Teva Pharmaceutical Ind. Ltd. Storage instructions and dispensing precautions are included on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.